Back
Grand Canyon Education, Inc. Vs. Regencell Bioscience Holdings Ltd. Industry Stock Comparison
Sell
41
LOPE
Grand Canyon Education, Inc.
Last Price:
$168.29
Seasonality Move:
5.96%
Buy
60
RGC
Regencell Bioscience Holdings Ltd.
Last Price:
$24.83
Seasonality Move:
163.53%
Sell
41
Grand Canyon Education, Inc. (LOPE)
is a Sell
Is Grand Canyon Education, Inc. a Buy, Sell or Hold?
-
The current Grand Canyon Education, Inc. [LOPE] share price is $168.21. The Score for LOPE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
LOPE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Regencell Bioscience Holdings Ltd. (RGC)
is a Buy
Is Regencell Bioscience Holdings Ltd. a Buy, Sell or Hold?
-
The current Regencell Bioscience Holdings Ltd. [RGC] share price is $24.60. The Score for RGC is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
RGC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LOPE Stock Price Chart
What is Grand Canyon Education, Inc.'s stock price today?
-
The Grand Canyon Education, Inc. share price today is $168.21The current trend is relatively stagnant and LOPE is experiencing slight selling pressure.
RGC Stock Price Chart
What is Regencell Bioscience Holdings Ltd.'s stock price today?
-
The Regencell Bioscience Holdings Ltd. share price today is $24.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGC is experiencing selling pressure, which indicates risk of future bearish movement.
LOPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.96 | Sell |
| Relative Strength Index (14 RSI): | 55.51 | Buy |
| Chaikin Money Flow: | -41112 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (154.39 - 164.51) | Buy |
| Bollinger Bands (100): | (167.57 - 213.35) | Sell |
RGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.97 | Buy |
| Relative Strength Index (14 RSI): | 79.86 | Buy |
| Chaikin Money Flow: | -349404 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.01 - 19.83) | Buy |
| Bollinger Bands (100): | (12.49 - 17.67) | Buy |
LOPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 165.95 | Buy |
| 20-day SMA: | 159.8 | Buy |
| 50-day SMA: | 175.6 | Sell |
| 200-day SMA: | 185.42 | Sell |
| 8-day EMA: | 165.48 | Buy |
| 20-day EMA: | 163.77 | Buy |
| 50-day EMA: | 172.42 | Sell |
| 200-day EMA: | 180.51 | Sell |
RGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.18 | Buy |
| 20-day SMA: | 16.85 | Buy |
| 50-day SMA: | 15.52 | Buy |
| 200-day SMA: | 13.19 | Buy |
| 8-day EMA: | 17.47 | Buy |
| 20-day EMA: | 9.82 | Buy |
| 50-day EMA: | 4.58 | Buy |
| 200-day EMA: | 1.24 | Buy |
Grand Canyon Education, Inc. Earnings Growth & LOPE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $0.85 per share.
Regencell Bioscience Holdings Ltd. Earnings Growth & RGC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Grand Canyon Education, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regencell Bioscience Holdings Ltd. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||